Trials / Completed
CompletedNCT06427915
Studying Glucose and Appetite Response With Alternatives to Soda Pop
Studying GlucOse anD Appetite ResponseS With Alternatives to Pop (SODA-SWAP)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Olipop, PBC · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The primary aim of this clinical trial is to determine the acute effects of OLIPOP (a lower sugar, high fiber prebiotic soda) consumption, compared to consumption of a commercially available sugar-sweetened soda pop, on blood glucose in response to the beverages alone and in combination with a carbohydrate-rich mixed lunch meal in free-living, generally healthy adults.This study will consist of one screening/randomization clinic visit (day 0) and one follow-up clinic visit (day 5), with participants consuming study products on their own (e.g., at home) following an assigned treatment sequence on days 1, 2, 3, and 4. The main questions answered by this trial are the impacts of a prebiotic rich soda versus a traditional soda on: 1) blood glucose levels with and without a meal, 2) perceived hunger levels, 3) perceived alertness levels and 4) total caloric intake.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | OLIPOP prebiotic soda | 12oz serving containing Carbonated Water, OLISMART(TM) (Cassava Root Fiber, Acacia Fiber, Guar Fiber, Nopal Cactus\*, Marshmallow Root\*, Calendula Flower\*, Kudzu Root\*), Cassava Root Syrup, Apple Juice Concentrate, Lime Juice, Natural Cola Flavor, Alpinia Galanga Root\*, Stevia Leaf\*, Himalayan Pink Salt, Green Tea Caffeine\*, Natural Caramel Flavor, Natural Vanilla Flavor, Cinnamon\* (\*Extract) |
| OTHER | Traditional sugar-sweetened cola | 12oz serving containing carbonated water, high fructose corn syrup, caramel color, phosphoric acid, natural flavors, caffeine |
Timeline
- Start date
- 2024-05-15
- Primary completion
- 2024-06-21
- Completion
- 2024-06-21
- First posted
- 2024-05-24
- Last updated
- 2025-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06427915. Inclusion in this directory is not an endorsement.